Theriva Biologics, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Theriva Biologics, Inc. (TOVX) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2023-03-30
- Theriva Biologics, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-06-30 was $0.00.
- Theriva Biologics, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Theriva Biologics, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-12-31 was $0.00.
- Theriva Biologics, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-09-30 was $0.00.
- Theriva Biologics, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $0.00.
- Theriva Biologics, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2021 was -$1.00K.
- Theriva Biologics, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2020 was -$73.00K.
- Theriva Biologics, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2019 was -$77.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-30 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 2 quarters · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $0.00 derived: sum of 4 quarters · filed 2023-03-30 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $0.00 derived: sum of 4 quarters · filed 2023-03-30 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | -$1.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-08-11 | -$1.00K 10-Q · filed 2022-11-10 | -$22.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | -$1.00K 10-Q · filed 2022-08-11 | -$22.00K derived: sum of 3 quarters · filed 2022-11-10 | -$30.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-03-31 | $1.00K 10-Q · filed 2022-11-10 | -$1.00K 10-Q · filed 2021-05-05 | -$22.00K derived: sum of 2 quarters · filed 2022-11-10 | -$30.00K derived: sum of 3 quarters · filed 2022-11-10 | -$46.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2020-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | -$31.00K derived: sum of 2 quarters · filed 2022-03-16 | -$47.00K derived: sum of 3 quarters · filed 2022-03-16 | -$73.00K 10-K · filed 2022-03-16 | |
| 2020-09-30 | -$8.00K 10-Q · filed 2021-11-03 | -$24.00K derived: sum of 2 quarters · filed 2021-11-03 | -$50.00K 10-Q · filed 2021-11-03 | -$54.00K derived: sum of 4 quarters · filed 2021-11-03 | |
| 2020-06-30 | -$16.00K 10-Q · filed 2021-11-03 | -$42.00K 10-Q · filed 2021-08-05 | -$46.00K derived: sum of 3 quarters · filed 2021-11-03 | -$76.00K derived: sum of 4 quarters · filed 2021-11-03 | |
| 2020-03-31 | -$26.00K 10-Q · filed 2021-11-03 | -$30.00K derived: sum of 2 quarters · filed 2021-11-03 | -$60.00K derived: sum of 3 quarters · filed 2021-11-03 | -$87.00K derived: sum of 4 quarters · filed 2021-11-03 | |
| 2019-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$34.00K derived: sum of 2 quarters · filed 2021-03-04 | -$61.00K derived: sum of 3 quarters · filed 2021-03-04 | -$77.00K 10-K · filed 2021-03-04 | |
| 2019-09-30 | -$30.00K 10-Q · filed 2020-11-10 | -$57.00K derived: sum of 2 quarters · filed 2020-11-10 | -$73.00K 10-Q · filed 2020-11-10 | -$92.00K derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | -$27.00K 10-Q · filed 2020-11-10 | -$43.00K 10-Q · filed 2020-08-06 | -$62.00K derived: sum of 3 quarters · filed 2020-11-10 | -$71.00K derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-03-31 | -$16.00K 10-Q · filed 2020-11-10 | -$35.00K derived: sum of 2 quarters · filed 2020-11-10 | -$44.00K derived: sum of 3 quarters · filed 2020-11-10 | -$60.00K derived: sum of 4 quarters · filed 2020-11-10 | |
| 2018-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$28.00K derived: sum of 2 quarters · filed 2020-02-20 | -$44.00K derived: sum of 3 quarters · filed 2020-02-20 | -$54.00K 10-K · filed 2020-02-20 | |
| 2018-09-30 | -$9.00K 10-Q · filed 2019-11-04 | -$25.00K derived: sum of 2 quarters · filed 2019-11-04 | -$35.00K 10-Q · filed 2019-11-04 | -$72.00K derived: sum of 4 quarters · filed 2019-11-04 | |
| 2018-06-30 | -$16.00K 10-Q · filed 2019-11-04 | -$17.00K 10-Q · filed 2018-08-08 | -$26.00K 10-Q · filed 2019-08-08 | -$63.00K derived: sum of 3 quarters · filed 2019-11-04 | -$71.00K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-03-31 | -$9.00K 10-Q · filed 2019-11-04 | -$10.00K 10-Q · filed 2018-05-08 | -$47.00K derived: sum of 2 quarters · filed 2019-11-04 | -$55.00K derived: sum of 3 quarters · filed 2019-11-04 | -$115.00K derived: sum of 4 quarters · filed 2019-11-04 |
| 2017-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$46.00K derived: sum of 2 quarters · filed 2019-02-27 | -$106.00K derived: sum of 3 quarters · filed 2019-02-27 | -$318.00K 10-K · filed 2019-02-27 | |
| 2017-09-30 | -$8.00K 10-Q · filed 2018-11-08 | -$68.00K derived: sum of 2 quarters · filed 2018-11-08 | -$280.00K 10-Q · filed 2018-11-08 | -$377.00K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | -$60.00K 10-Q · filed 2018-08-08 | -$272.00K 10-Q · filed 2018-08-08 | -$369.00K derived: sum of 3 quarters · filed 2018-08-08 | -$505.00K derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | -$212.00K 10-Q · filed 2018-05-08 | -$309.00K derived: sum of 2 quarters · filed 2018-05-08 | -$445.00K derived: sum of 3 quarters · filed 2018-05-08 | -$527.00K derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | -$97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$233.00K derived: sum of 2 quarters · filed 2018-02-22 | -$315.00K derived: sum of 3 quarters · filed 2018-02-22 | -$548.00K 10-K · filed 2018-02-22 | |
| 2016-09-30 | -$136.00K 10-Q · filed 2017-11-01 | -$218.00K derived: sum of 2 quarters · filed 2017-11-01 | -$451.00K 10-Q · filed 2017-11-01 | -$766.00K derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-06-30 | -$82.00K 10-Q · filed 2017-08-03 | -$315.00K 10-Q · filed 2017-08-03 | -$630.00K derived: sum of 3 quarters · filed 2018-02-22 | -$1.36M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-03-31 | -$233.00K 10-Q · filed 2017-05-04 | -$548.00K derived: sum of 2 quarters · filed 2018-02-22 | -$1.28M derived: sum of 3 quarters · filed 2018-02-22 | -$1.28M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2015-12-31 | -$315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$1.05M derived: sum of 2 quarters · filed 2018-02-22 | -$1.05M derived: sum of 3 quarters · filed 2018-02-22 | -$1.05M 10-K · filed 2018-02-22 | |
| 2015-09-30 | -$733.00K 10-Q · filed 2016-11-01 | -$733.00K derived: sum of 2 quarters · filed 2016-11-01 | -$733.00K 10-Q · filed 2016-11-01 | -$733.00K derived: sum of 4 quarters · filed 2017-03-02 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-03 | $0.00 10-Q · filed 2016-08-03 | $0.00 derived: sum of 3 quarters · filed 2017-03-02 | $0.00 derived: sum of 4 quarters · filed 2017-03-02 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $0.00 derived: sum of 3 quarters · filed 2017-03-02 | $0.00 derived: sum of 4 quarters · filed 2017-03-02 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $0.00 derived: sum of 3 quarters · filed 2017-03-02 | $0.00 10-K · filed 2017-03-02 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | -$1.00K derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | -$1.00K derived: sum of 3 quarters · filed 2016-03-10 | -$1.00K derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | -$1.00K derived: sum of 2 quarters · filed 2016-03-10 | -$1.00K derived: sum of 3 quarters · filed 2016-03-10 | -$1.00K derived: sum of 4 quarters · filed 2016-03-10 | |
| 2013-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$1.00K derived: sum of 2 quarters · filed 2016-03-10 | -$1.00K derived: sum of 3 quarters · filed 2016-03-10 | -$1.00K 10-K · filed 2016-03-10 | |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-14 | $0.00 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 | $0.00 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-15 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |